Denna webbsida är endast avsedd för läkare och sjukvårdspersonal med förskrivningsrätt.

SCANPROST Meeting: A Scandinavian meeting to discuss recent developments in prostate cancer

During recent years we have seen an accelerating pace in the development and adoption of new techniques in diagnosis and treatment of prostate cancer. This has led to earlier treatment, improved outcomes, and longer life for many patients. It is therefore our great pleasure to invite you to this year’s SCANPROST meeting to discuss and assess some of these recent developments.

SCANPROST Meeting – Read more on the invitation here

Malmö Live Clarion Hotel – Malmö, Sweden

Date: 8–9 December 2022

Time: 12.30 (Thursday December 8th) – 11.30 (Friday December 9th)

Last registration date: November 25

Click here to register

Warm welcome from Janssen Oncology on behalf of the SCANPROST Scientific Steering Committee:

  • Anders Bjartell, Professor, Urological cancer, Malmö and Division of Translational Cancer Research, Lund university, Sweden.
  • Michael Borre, Professor, Department of Clinical Medicine and Department of Urology, Aarhus University, Denmark.
  • Henrik Grönberg, Professor, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm and Capio St:Görans Hospital, Sweden.

Additional speakers:

  • Anna Bill-Axelsson, Professor of Urology, Department of Surgical Sciences, Uppsala University, Sweden.
  • Noel Clarke, Consultant Urological Surgeon, Professor of Urological Oncology, The Christie Hospital Manchester, England.
  • Philip Cornford, Associate clinical Professor Department of Urology, Liverpool University Hospitals, England.
  • Stefano Fanti, Professor, Diagnostic Imaging, University of Bologna, Italy.
  • Marcus Graefen, Professor of Urology & Chairman of Martini-Klinik, Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf, Germany.
  • Fredrik Jäderling, PhD, Radiologist, Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, and Dept. of Radiology Capio St:Görans Hospital, Sweden.
  • Laura-Maria Krabbe, Professor, Department of Urology, The University of Muenster Medical Center, Germany.
  • Johan Lindberg, Senior Researcher, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Sweden.
  • Tobias Maurer, Professor, Faculty Martini-Klinik and Department of Urology, University of Hamburg-Eppendorf, Germany.
  • Andreas Røder, Professor, Department of Urology and Copenhagen Prostate Cancer Center, Rigshospitalet, Denmark.

Additional information:

This meeting is free of charge for its participants as Janssen finances this meeting. According to the agreement between LIF and SKR, pharmaceutical companies may not cover the cost of either travel or accommodation. For this reason, each participant is responsible for booking and paying its own travel and accommodation. Remember: the participant is responsible for the employer’s approval to participate in the meeting.

For questions regarding registration, contact:

Karin Ekenberg, Business Operations Specialist Janssen

Email: [email protected]

Phone: +46 73 665 39 84

For questions regarding the event, contact:

Anna Sandqvist, PhD, Medical Advisor Janssen

Email: [email protected]

Phone: +46 72 545 24 23

Liknande poster

CHMP ger ett positivt utlåtande gällande Carvykti för behandling av relapserad och refraktär multipelt myelom

Janssen lanserar en enklare Erleada-dosering för patienter med avancerad prostatacancer

Janssen ansöker om EMA-godkännande för Rybrevant